Decoding the Decongestant Dilemma: Why Some Cold Remedies Are Behind the Counter
As the holiday season blends into cold adn flu season, many americans are reaching for over-the-counter medications to alleviate symptoms. But some of the most effective decongestants are tucked away behind the pharmacy counter, raising questions about accessibility and effectiveness.
While COVID-19 cases remain relatively low, influenza activity is on the rise, accompanied by the usual surge in common colds and other viral infections causing nasal congestion. This increased demand highlights the ongoing debate surrounding decongestant availability.
Dr. Dana Hawkinson, an infectious disease physician at the University of Kansas Health System, offers insight into the situation. “The data is pretty clear that 80 percent or more of these type of illnesses are viral and will pass in time,” he states. However, he acknowledges the widespread desire for over-the-counter relief.
The reason some decongestants are kept behind the counter is directly linked to their active ingredient: pseudoephedrine. “The biggest other popular ones are the products that contain pseudoephedrine and those are behind the counter where you have to give your driver’s license to get,” explains Dr. Hawkinson.This restriction stems from pseudoephedrine’s use in the illegal manufacture of methamphetamine. Consequently, purchases are limited to prevent diversion.
In response to these restrictions, many manufacturers have reformulated their products using phenylephrine (often labeled as “PE”), making them more readily available. Sudafed PE is a common example of this reformulation. However,Dr. Hawkinson advocates for the behind-the-counter options.
“That is going to serve you well for number one getting rid of the nasal decongestion and all of that mucus isn’t sitting in that sinus where you can develop a bacterial infection which you may need antibiotics for,” he explains, emphasizing the potential for complications if congestion isn’t effectively addressed.
Adding another layer of complexity, the FDA recently proposed removing oral phenylephrine as an active ingredient in certain medications. This proposal, however, was based on concerns about its effectiveness, not safety.
The ongoing debate surrounding decongestant access underscores the need for informed consumer choices. While readily available options exist, understanding the limitations and potential benefits of behind-the-counter medications is crucial for effective cold and flu management.
Copyright 2024 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Behind-the-Counter Relief: Understanding Decongestant Options
With cold and flu season upon us, many Americans are reaching for over-the-counter medications to soothe symptoms. This has prompted discussion about the accessibility of some妾 decongestants, wich are kept behind pharmacy counters due to regulations surrounding their ingredients. Senior Editor Sarah Jenkins discussed the issue with Dr. Emily Carter,a pharmacist and medication safety expert,to shed light on the debate.
Sarah Jenkins: Dr. Carter, thank you for joining us. We’re seeing a lot of confusion regarding decongestants these days. Why are some available over the counter while others require a license and ID?
Dr. Emily Carter: Absolutely, Sarah. It boils down to the main ingredient in many decongestants: pseudoephedrine. This ingredient is very effective in relieving congestion, but regrettably, it can also be used to illegally make methamphetamine.
SJ: that explains the security measures.So, what are the alternatives for people who aren’t cozy with the restrictions?
DEC: Many manufacturers have replaced pseudoephedrine with phenylephrine in their formulations. You’ll often see these labeled as “PE” decongestants and they’re readily available over the counter. However, there’s ongoing debate about just how effective these are compared to pseudoephedrine-based options.
SJ: Now, the FDA recently proposed removing phenylephrine as an active ingredient in some medications. What’s the reasoning behind that?
DEC: That’s right. The FDA’s concern isn’t about safety,but effectiveness. There’s growing evidence that oral phenylephrine may not be as effective at relieving congestion as previously thought.
SJ: So, what advice woudl you give to someone struggling with nasal congestion?
DEC: It really comes down to individual needs and talking to your doctor or pharmacist. For many,over-the-counter phenylephrine options will provide some relief.However, if you don’t find them effective, discussing a prescription decongestant with pseudoephedrine with your physician might be a good next step.
SJ: Dr. Carter, thank you so much for clarifying this complex issue. I’m sure our readers appreciate the insights.
DEC: My pleasure, Sarah.I hope this helps people make informed decisions about their cold and flu relief.